BOCOCIZUMAB vs BOSUTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BOCOCIZUMAB vs BOSUTINIB: Safety Overview
| Metric | BOCOCIZUMAB | BOSUTINIB |
|---|---|---|
| Total FAERS Reports | 122 | 7,777 |
| Deaths Reported | 1 | 680 |
| Death Rate | 0.8% | 8.7% |
| Hospitalizations | 114 | 1,675 |
| Average Patient Age | 61.8 yrs | 64.7 yrs |
| % Female Patients | 27.1% | 51.8% |
| FDA Approval Date | N/A | May 23, 2025 |
| Manufacturer | N/A | U.S. Pharmaceuticals |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |